Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (II);¿Existe la enfermedad de Alzheimer en todos los primates? Patología Alzheimer en primates no humanos y sus implicaciones fisiopatológicas (II)

Neurologia

Volumn 29, Issue 1, 2014, Pages 42-55

  Toledano, A ^a   Alvarez M I ^a   Lopez Rodriguez A B ^a   Toledano Diaz A ^b   Fernandez Verdecia C I ^c  

^a INSTITUTO CAJAL   (Spain)

^b INIA   (Spain)

^c CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

Author keywords

Ageing; Alzheimer models; Alzheime s Disease; Amyloid; Behaviour; Cognitive functions; Non human primates; Senility; Tau protein

Indexed keywords

ALZHEIMER DISEASE; ANIMAL; HUMAN; PATHOLOGY; PRIMATE; PRIMATE DISEASE;

ALZHEIMER DISEASE; ANIMALS; HUMANS; PRIMATE DISEASES; PRIMATES;

EID: 84895067148     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2011.05.004     Document Type: Short Survey

References (92)

1. Toledano A, Álvarez MI, López-Rodríguez AB, Toledano-Díaz A, Fernández-Verdecia CI. ¿Existe la enfermedad de alzheimer en todos los primates? Patología alzheimer en primates no humanos y sus implicaciones fisiopatológicas (I). Neurología. doi:10.1016/j.neurobiolaging.2010.06.003.
2. Bons N., Rieger F., Prudhomme D., Fisher A., Krause K-H Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease?. Genes, Brain and Behavior 2006, 5:120-130.
3. Silhol S., Calenda A., Jallageas V., Mestre-Frances N., Bellis M., Bons N. Beta-amyloid protein precursor in Microcebus murinus: genotyping and brain localization. Neurobiol Dis 1996, 3:169-182.
4. Giannakopoulos P., Silhol S., Jallageas V., Mallet J., Bons N., Bouras C., et al. Quantitative analysis of tau protein-immunoreactive accumulations and beta amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus. Acta Neuropathol (Berl) 1997, 94:131-139.
5. Bons N., Mestre N., Ritchie K., Petter A., Podlisny M., Selkoe D. Identification of amyloid beta protein in the brain of the small, short-lived lemurian primate Microcebus murinus. Neurobiol Aging 1994, 15:215-220.
6. Calenda A., Mestre-Frances N., Czech C., Pradier L., Petter A., Perret M., Bons N., et al. Cloning of the presenilin 2 cDNA and its distribution in brain of the primate, Microcebus murinus: coexpression with betaAPP and Tau proteins. Neurobiol Dis 1998, 5:323-333.
7. Trouche S.G., Maurice T., Rouland S., Verdier J.M., Mestre-Francés N. The three-panel runway maze adapted to Microcebus murinus reveals age-related differences in memory and perseverance performances. Neurobiol Learn Mem 2010, 94:100-106.
8. Trouche S.G., Asuni A., Rouland S., Wisniewski T., Frangione B., Verdier J.M., et al. Antibody response and plasma Abeta1-40 levels in young Microcebus murinus primates immunized with Abeta1-42 and its derivatives. Vaccine 2009, 27:957-964.
9. Kanemaru K., Iwatsubo T., Ihara Y. Comparable amyloid beta-protein (A beta) 42(43) and A beta 40 deposition in the aged monkey brain. Neurosci Lett 1996, 214:196-198.
10. McGuire M.T. The St Kitts vervet (cercopithecus aethiops). J Med Primatol 1974, 3:285-297.
11. Palmour R.M., Mulligan J., Howbert J.J., Ervin F. Of monkeys and men: vervets and the genetics of human-like behaviors. Am J Hum Genet 1997, 61:481-488.
12. Lemere C.A., Beierschmitt A., Iglesias M., Spooner E.T., Bloom J.K., Leverone J.F., et al. Alzheimer's disease Abeta vaccine reduces central nervous system Abeta levels in a non-human primate, the Caribbean vervet. Am J Pathol 2004, 165:83-97.
13. Voytko M.L., Tinker G.P. Cognitive function and its neural mechanism in nonhuman primate models of aging, Alzheimer's diseases, and menopause. Front Biosci 2004, 9:1899-1914.
14. Bachevalier J., Landis L.S., Walker L.C., Brickson M., Mishkin M., Price D.L., et al. Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction. Neurobiol Aging 1991, 12:99-111.
15. Uno H., Walker L.C. The age of biosenescence and the incidence of cerebral beta-amyloidosis in aged captive Rhesus monkeys. Ann N Y Acad Sci 1993, 695:232-235.
16. The Cayo Santiago macaques. History, behavior and biology 1986, State University of New York Press, Albany. R.G. Rawlins, M.J. Kessler (Eds.).
17. Sani S., Traul D., Klink A., Niaraki N., Gonzalo-Ruiz A., Wu C.K., et al. Distribution, progression and chemical composition of cortical amyloid-beta deposits in aged Rhesus monkeys: similarities to the human. Acta Neuropathol (Berl) 2003, 105:145-156.
18. Nakamura S., Nakayama H., Goto N., Ono F., Sakakibara I., Yoshikawa Y. Histopathological studies of senile plaques and cerebral amyloidosis in cynomolgus monkeys. J Med Primatol 1998, 27:244-252.
19. Kimura N., Tanemura K., Nakamura S., Takashima A., Ono F., Sakakibara I., et al. Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains. Biochem Biophys Res Commun 2003, 310:303-311.
20. Voytko M.L. Impairements in acquisition and reversal of two-choice discriminations by aged Rhesus monkeys. Neurobiol Aging 1999, 20:617-627.
21. Gearing M., Tigges J., Mori H., Mirra S. Abeta40 is a major form of beta-amyloid in nonhuman primates. Neurobiol Aging 1996, 17:903-908.
22. Toledano A., Alvarez M.I. Lesions and dysfunctions of the nucleus basalis as Alzheimer's disease models: general and critical overview and analysis of the long-term changes in several excitotoxic models. Curr Alz Res 2004, 1:189-214.
23. Toledano A., Álvarez M.I. Lesion-induced vertebrate models of Alzheimer dementia. Animal models of dementia 2010, 295-345. Humana Press, New York. P.P. Deyn, D. Van Dam (Eds.).
24. Ramirez M.J., Ridley R.M., Baker H.F., Maclean C.J., Honer W.G., Francis P.T. Chronic elevation of amyloid precursor protein in the neocortex or hippocampus of marmosets with selective cholinergic lesions. J Neural Transm 2001, 108:809-826.
25. Aigner T.G., Mitchell S.J., Aggleton J.P., DeLong M.R., Struble R.G., Price D.L., et al. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Psychopharmacology 1987, 92:292-300.
26. Aigner T.G., Mitchell S.J., Aggleton J.P., DeLong M.R., Struble R.G., Price D.L., et al. Transient impairment of recognition memory following ibotenic-acid lesions of the basal forebrain in macaques. Exp Brain Res 1991, 86:18-26.
27. Irle E., Markowitsch H.J. Basal forebrain-lesioned monkeys are severely impaired in tasks of association and recognition memory. Ann Neurol 1987, 22:735-743.
28. Ridley R.M., Baker H.F., Drewwtt B., Johnson J.A. Effects of ibotenic acid leisons of the basal forebrain on serial reversal learning in marmosets. Psychopharmacology 1985, 86:438-443.
29. Ridley R.M., Murray T.K., Johnson J.A., Baker H.F. Learning impairment following lesion of the nucleus of Meynert in marmoset: modification by cholinergic drugs. Brain Res 1986, 376:108-116.
30. Li W., Wu Y., Min F., Li Z., Huang J., Huang R. A nonhuman primate model of Alzheimer's disease generated by intracranial injection of amyloid-beta42 and thiorphan. Metab Brain Dis 2010, 25:277-284.
31. Wenk, Gary L. A primate model of Alzheimer's disease. Behav Brain Res 1993, 57:117-122.
32. McKee A.C., Kowall N.W., Schumacher J.S., Beal M.F. The neurotoxicity of amyloid beta protein in aged primates. Amyloid 1998, 5:1-9.
33. Podlisny M.B., Stephenson D.T., Frosch M.P., Tolan D.R., Lieberburg I., Clemens J.A., et al. Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity. Am J Pathol 1993, 142:17-24.
34. Baker H.F., Ridley R.M., Duchen L.W., Crow T.J., Bruton C.J. Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. Int J Exp Pathol 1993, 74:441-454.
35. Baker H.F., Ridley R.M., Duchen L.W., Crow T.J., Bruton C.J. Experimental induction of beta-amyloid plaques and cerebral angiopathy in primates. Ann N Y Acad Sci 1993, 695:228-231.
36. Maclean C.J., Baker H.F., Ridley R.M., Mori H. Naturally occurring and experimentally induced beta-amyloid deposits in the brains of marmosets (Callithrix jacchus). J Neural Transm 2000, 107:799-814.
37. Ridley R.M., Baker H.F., Windle C.P., Cummings R.M. Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm 2006, 113:1243-1251.
38. Baker H.F., Ridley R.M., Duchen L.W., Crow T.J., Bruton C.J. Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol 1994, 8:25-39.
39. McArthur R.A., Gray J., Schreiber R. Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials. Curr Opin Investig Drugs 2010, 11:740-760.
40. Toyohara J., Ishiwata K., Sakata M., Wu J., Nishiyama S., Tsukada H., et al. In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys. PLoS One 2010, 5:e8961.
41. Asai M., Fujikawa A., Noda A., Miyoshi S., Matsuoka N., Nishimura S. Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious Rhesus monkeys. Ann Nucl Med 2009, 23:877-882.
42. Nagahara A.H., Merrill D.A., Coppola G., Tsukada S., Schroeder B.E., Shaked G.M., et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 2009, 15:331-337.
43. Cook J.J., Wildsmith K.R., Gilberto D.B., Holahan M.A., Kinney G.G., Mathers P.D., et al. Acute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments without amyloid-beta rebound. J Neurosci 2010, 30:6743-6750.
44. Sankaranarayanan S., Holahan M.A., Colussi D., Crouthamel M.C., Devanarayan V., Ellis J., et al. First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates. J Pharmacol Exp Ther 2009, 328:131-140.
45. Gandy S., DeMattos R.B., Lemere C.A., Heppner F.L., Leverone J., Aguzzi A., et al. Alzheimer A beta vaccination of Rhesus monkeys (Macaca mulatta). Alzheimer Dis Assoc Disord 2004, 18:44-46.
46. Gandy S., DeMattos R.B., Lemere C.A., Heppner F.L., Leverone J., Aguzzi A., et al. Alzheimer's Abeta vaccination of Rhesus monkeys (Macaca mulatta). Mech Ageing Dev 2004, 125:149-151.
47. Lemere C.A., Beierschmitt A., Iglesias M., Spooner E.T., Bloom J.K., Leverone J.F., et al. Alzheimer's disease Abeta vaccine reduces central nervous system Abeta levels in a non-human primate, the Caribbean vervet. Am J Pathol 2004, 165:283-297.
48. Li S.B., Wang H.Q., Lin X., Xu J., Xie Y., Yuan Q.F., et al. Specific humoral immune responses in Rhesus monkeys vaccinated with the Alzheimer's disease-associated beta-amyloid 1-15 peptide vaccine. Chin Med J (Engl) 2005, 118:660-664.
49. Lemere C.A., Maier M., Jiang L., Peng Y., Seabrook T.J. Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans. Rejuvenation Res 2006, 9:77-84.
50. Britschgi M., Olin C.E., Johns H.T., Takeda-Uchimura Y., LeMieux M.C., Rufibach K., et al. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc Natl Acad Sci U S A 2009, 106:12145-12150.
51. Qin W., Chachich M., Lane M., Roth G., Bryant M., De Cabo R., et al. Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). J Alzheimers Dis 2006, 10:417-422.
52. Willette A.A., Gallagher C., Bendlin B.B., McLaren D.G., Kastman E.K., Canu E., et al. Homocysteine, neural atrophy, and the effect of caloric restriction in Rhesus monkeys. Neurobiol Aging 2010, (En prensa).
53. Wu J., Basha MdR, Brock B., Cox D.P., Cardozo-Pelaez F., McPherson C.A., et al. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J Neurosci 2008, 28:3-9.
54. Basha M.R., Wei W., Bakheet S.A., Benitez N., Siddiqi H.K., Ge Y.W., et al. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and -amyloid in the aging brain. J Neurosci 2005, 25:823-829.
55. Niklowitz W.J., Mandybur T.I. Neurofibrillary changes following childhood lead encephalopathy. J Neuropathol Exp Neurol 1985, 34:445-455.
56. Barker D.J., Winter P.D., Osmond C., Margetts B., Simmonds S.J. Weight in infancy and death from ischaemic heart disease. Lancet 1989, 2:577-580.
57. Osmond C., Barker D.J. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect 2000, 108:545-553.
58. Guilarte T.R. APLP1, Alzheimer's-like pathology and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. Neurotoxicology 2010, 31:572-574.
59. Price D.L., Martin L.J., Sisodia S.S., Wagster M.V., Koo E.H., Walker L.C., et al. Aged non-human primates: an animal model of age-associated neurodegenerative disease. Brain Pathol 1991, 1:287-296.
60. Gearing M., Rebeck G.W., Hyman B.T., Tigges J., Mirra S.S. Neuropathology and apolipoprotein E profile of aging chimpanzees: implications for Alzheimer disease. Proc Natl Acad Sci U S A 1994, 91:9382-9386.
61. Selkoe D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 2008, 192:106-113.
62. Cork L.C., Powers R.E., Selkoe D.J., Davies P., Geyer J.J., Price D.L. Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol 1988, 47:629-641.
63. Pawlik M., Fuchs E., Walker L.C., Levy E. Primate-like amyloid-beta sequence but no cerebral amyloidosis in aged tree shrews. Neurobiol Aging 1999, 20:47-51.
64. Gearing M., Tigges J., Mori H., Mirra S.S. beta-Amyloid (A beta) deposition in the brains of aged orangutans. Neurobiol Aging 1997, 18:139-146.
65. Lemere C.A., Oh J., Stanish H.A., Peng Y., Pepivani I., Fagan A.M., et al. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?. Rejuvenation Res 2008, 11:321-332.
66. Rosen R.F., Farberg A.S., Gearing M., Dooyema J., Long P.M., Anderson D.C., et al. Tauopathy with paired helical filaments in an aged chimpanzee. J Comp Neurol 2008, 509:259-270.
67. Walker L.C., Rosen R.F., Levine H. Diversity of Abeta deposits in the aged brain: a window on molecular heterogenity?. Rom J Morphol Embryol 2008, 49:5-11.
68. Chambers J.K., Kuribayashi H., Ikeda S., Une Y. Distribution of neprilysin and deposit patterns of Abeta subtypes in the brains of aged squirrel monkeys (Saimiri sciureus). Amyloid 2010, 17:75-82.
69. Kraska A., Dorieux O., Picq J.L., Petit F., Bourrin E., Chenu E., et al. Age-associated cerebral atrophy in mouse lemur primates. Neurobiol Aging 2011, 32:894-906.
70. Ichinohe N., Hayashi M., Wakabayashi K., Rockland K.S. Distribution and progression of amyloid-beta deposits in the amygdala of the aged macaque monkey, and parallels with zinc distribution. Neuroscience 2009, 159:1374-1383.
71. Oikawa N., Kimura N., Yanagisawa K. Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition. Brain Res 2010, 1315:137-149.
72. Shah P., Lal N., Leung E., Traul D.E., Gonzalo-Ruiz A., Geula C. Neuronal and axonal loss are selectively linked to fibrillar amyloid-{beta} within plaques of the aged primate cerebral cortex. Am J Pathol 2010, 177:325-333.
73. Cai Y., Xiong K., Zhang X.M., Cai H., Luo X.G., Feng J.C., et al. Beta-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and beta-amyloid accumulation. Eur J Neurosci 2010, 18:1223-1238.
74. Brizee K.R., Ordy J.M., Bartus R.T. Localization of cellular changes within multimodal sensory regions in aged monkey brain: possible implications for aged-related cognitive less. Neurobiol Aging 1980, 1:45-52.
75. Cupp C.J., Uemura E. Aged-related changes in prefrontal cortex of Maccaca mulatta: quantitative analysis of dendritic branching patterns. Exp Neurol 1980, 69:143-163.
76. Keuker J.I., Luiten P.G., Fuchs E. Preservation of hippocampal neuron numbers in aged Rhesus monkeys. Neurobiol Aging 2003, 24:157-165.
77. Rapp P.R., Amaral D.G. Evidence for task-dependent memory dysfunction in the aged monkey. J Neurosci 1989, 9:3568-3576.
78. Craik F.I.M., Byrd M., Swanson J.M. Patterns of memory loss in three elderly samples. Psychol Aging 1987, 2:79-86.
79. Capitanio J.P., Emborg M.E. Contributions of non-human primates to neuroscience research. Lancet 2008, 371:1126-1135.
80. Nagahara A.H., Bernot T., Tuszynski M.H. Age-related cognitive deficits in Rhesus monkeys mirror human deficits on an automated test battery. Neurobiol Aging 2010, 31:1020-1031.
81. Buccafusco J.J. Estimation of working memory in macaques for studying drugs for the treatment of cognitive disorders. J Alzheimers Dis 2008, 15:709-720.
82. Moss M.B., Moore T.L., Schettler S.P., Killiany R., Rosene D. Successful vs. unsuccessful aging in the Rhesus monkey. Brain aging: models, methods, and mechanisms. Frontiers in neuroscience 2007, CRC Press, Boca Raton. D.R. Riddle (Ed.).
83. Rosen R.F., Walker L.C., Levine H. PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol Aging 2011, 32:223-234.
84. Rapoport S.I. Hypothesis: Alzheimer's disease is a phylogenetic disease. Med Hypotheses 1989, 29:147-150.
85. Albert M.S. Neuropsychological and neurophysiological changes in healthy adult humans across the age range. Neurobiol Aging 1993, 14:623-625.
86. Forlenza O.V., Diniz B.S., Gattaz W.F. Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Med 2010, 8:89.
87. Perls T.T. The different paths to 100. Am J Clin Nutr 2006, 83:485S-487S.
88. Nelson P.T., Stefansson K., Gulcher J., Saper C.B. Molecular evolution of tau protein: implications for Alzheimer's disease. J Neurochem 1996, 67:1622-1632.
89. Wallace D.C., Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci U S A 1994, 91:8739-8746.
90. Bufill E., Blesa R. Enfermedad de Alzheimer y evolución cerebral. ¿Es la enfermedad de Alzheimer un ejemplo de pleiotropía antagonística?. Rev Neurol 2006, 42:25-33.
91. Vamathevan J.J., Hasan S., Emes R.D., Amrine-Madsen H., Rajagopalan D., Topp S.D., et al. The role of positive selection in determining the molecular cause of species differences in disease. BMC Evol Biol 2008, 8:273.
92. Finnerty J.R., Wang W.X., Hébert S.S., Wilfred B.R., Mao G., Nelson P.T. The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol 2010, 402:491-509.